# Biohaven Pharmaceutical
 (stock symbol: BHVN) Logo in transparent PNG and SVG formats

## Biohaven Pharmaceutical
 Logo large

### Biohaven Pharmaceutical
 Logo large Download PNG (31.42 KB)

![Biohaven Pharmaceutical
 Logo large Download PNG (31.42 KB)](/img/orig/BHVN_BIG-b255c404.png)

### Biohaven Pharmaceutical
 Logo large Download SVG (3.8 KB)

![Biohaven Pharmaceutical
 Logo large Download SVG (3.8 KB)](/img/orig/BHVN_BIG-7e1fad2e.svg)

## Biohaven Pharmaceutical
 Logo icon format

### Biohaven Pharmaceutical
 Logo icon format Download PNG (43.66 KB)

![Biohaven Pharmaceutical
 Logo icon format Download PNG (43.66 KB)](/img/orig/BHVN-e41fdb34.png)

### Biohaven Pharmaceutical
 Logo icon format Download SVG (1.5 KB)

![Biohaven Pharmaceutical
 Logo icon format Download SVG (1.5 KB)](/img/orig/BHVN-11d0cbb3.svg)

## Biohaven Pharmaceutical
 Logo large for dark backgrounds

### Biohaven Pharmaceutical
 Logo large for dark backgrounds Download PNG (20.21 KB)

![Biohaven Pharmaceutical
 Logo large for dark backgrounds Download PNG (20.21 KB)](/img/orig/BHVN_BIG.D-7ca4c941.png)

### Biohaven Pharmaceutical
 Logo large for dark backgrounds Download SVG (3.42 KB)

![Biohaven Pharmaceutical
 Logo large for dark backgrounds Download SVG (3.42 KB)](/img/orig/BHVN_BIG.D-09a85d55.svg)

## Biohaven Pharmaceutical
 Logo icon format for dark backgrounds

### Biohaven Pharmaceutical
 Logo icon format for dark backgrounds Download PNG (26.86 KB)

![Biohaven Pharmaceutical
 Logo icon format for dark backgrounds Download PNG (26.86 KB)](/img/orig/BHVN.D-e256f277.png)

### Biohaven Pharmaceutical
 Logo icon format for dark backgrounds Download SVG (1.48 KB)

![Biohaven Pharmaceutical
 Logo icon format for dark backgrounds Download SVG (1.48 KB)](/img/orig/BHVN.D-19e3e64b.svg)

## About Biohaven Pharmaceutical


Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an irreversible myeloperoxidase enzyme inhibitor for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial to treat spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in Sept 2022. The company was incorporated in 2022 and is headquartered in New Haven, Connecticut. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.

1. Website domain: biohavenpharma.com
2. Marketcap: $0.89 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
